STOP T1D

02/27/2026

Understand the signs, symptoms, and treatments for .

What is Type 1 Diabetes? - Getting Ahead of Type 1 Diabetes https://www.gettingaheadoftype1.org/what-is-type-1-diabetes -is-type-1-diabetes

Unlike other types of diabetes, type 1 diabetes (T1D) is a lifelong autoimmune disease that is currently not preventable or curable.

02/26/2026

New in : "Orbital Apex Syndrome (OAS) is a disease of multiple brain nerves at the orbital apex leading to vision loss and neurological impairments. Diabetes Mellitus (DM), a metabolic disorder with cardiovascular, immunological and neurological effects, is involved in OAS pathogenesis. However, the association between DM and OAS is not well studied. DM and OAS are poorly understood and may not be diagnosed correctly, especially when outbreaks such as COVID-19 are being investigated."

"The overview summarizes what clinicians need to do: Screen all OAS patients for DM, conduct stepwise diagnostic evaluations (including history taking and imaging tests), and MDT [multidisciplinary team] care to balance glycemic control with OAS treatment. Future work should focus on mechanistic biomarkers, diagnostic innovations, and personalized care for OAS patients."

Frontiers | Unveiling the hidden link: diabetes mellitus as a catalyst for orbital apex syndrome https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1770045/full

BackgroundOrbital Apex Syndrome (OAS) is a disease of multiple brain nerves at the orbital apex leading to vision loss and neurological impairments. Diabetes...

02/25/2026

Now we need to address affordability and access to get AIDs into use for more people managing their using CGMs.

"Results from this trial show the clinical efficacy of direct transition from multiple daily injections to tubeless AID in adults and children with type 1 diabetes, with no safety concerns, supporting AID as a therapeutic option within standard of care for people with type 1 diabetes."

"Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA1c (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trial" https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00364-X/abstract

Results from this trial show the clinical efficacy of direct transition from multiple daily injections to tubeless AID in adults and children with type 1 diabetes, with no safety concerns, supporting AID as a therapeutic option within standard of care for people with type 1 diabetes.

02/23/2026

Here's is the second live panel expert discussion hosted by The Sugar Science, made available for your viewing on YouTube: https://youtu.be/4rW_f6O8FL4?si=RBegxmb895czY9Cb

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

02/20/2026

In case you weren't able to attend this live panel discussion on screenings put on by The Sugar Science, it's now available to view on YouTube: https://youtu.be/jZIFm9YoxWU?si=wsbm49mtLSZC3E_i

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

02/20/2026

Health Care Providers: Why screen for pre-symptomatic type 1 diabetes? We have 5 good reasons to share with you from the Barbara Davis Center for Diabetes' Ask the Experts and STOP T1D programs.

Learn more:
AskTheExperts.org/for-providers
STOPT1Dprogram.org/for-HCP
BarbaraDavisCenter.org

02/18/2026

Know the signs and symptoms of type 1 diabetes!

See the accompanying graphic for the most common T1D symptoms.

To learn more, visit BarbaraDavisCenter.org and STOPT1Dprogram.org.

For no cost and disease screening information, visit ASKhealth.org

02/16/2026

⭐️ Health Care Providers and Medical Researchers!

Join us tomorrow, Tuesday, February 17 at 9 AM PST Noon EST for T1D Monitoring-Challenges for Implementation and Engagement

Hosted by The Sugar Science, our panelists include:
🔹 Brigitte Frohnert MD, PhD — University of Colorado, Anschutz
🔹 Kurt Griffin MD, PhD — Benaroya Research Institute
🔹 Kimber Simmons MD, MS — University of Colorado, Anshcutz
🔹 Jennifer Law MD, MSCR — University of North Carolina

AGENDA includes:
• Goals of monitoring: Prevent DKA; intervention; immunologic phenotyping (TCR phenotypes)
• Strategies for monitoring: A1c, OGTT, CGM
• PLEDGE monitoring overview
• ASK monitoring overview
• Early Check monitoring overview
• Q&A Session

Register: https://us02web.zoom.us/meeting/register/nq5ExonlTR-S5qIbqD6wOg

02/13/2026

🔔 EVENT REMINDER - Wednesday, February 18: Health Care Providers - This upcoming "Ask the Experts" Office Hours is an interactive 1-hr Zoom call to discuss early questions and cases.

Hosted by the Ask the Experts Team at the Barbara Davis Center for Diabetes

Mark your calendar to attend: Wednesday, February 18, 2026 | NOON – 1:00 PM (MST)

Participants may earn 1 credit for attending this session.

Register to attend: Office Hours | Ask the Experts >

Registration Form for our monthly "Office Hours" Zoom call for HCPs — to discuss early T1D questions and cases.

02/12/2026

The Barbara Davis Center for Diabetes' (BDC) research goals include investigation of the causes of type 1 diabetes, the early detection of autoimmunity, prevention and early intervention. In addition, BDC is developing new treatments, including a focus on the artificial pancreas, and prevention strategies for complications of both type 1 and type 2 diabetes, and the outcomes of care of type 1 diabetes.

Learn more about our research: https://medschool.cuanschutz.edu/barbara-davis-center-for-diabetes/research

STOPT1Dprogram.org is a BDC program providing education and resource information for Health Care Providers ( ) by offering meaningful Continuing Medical Education ( ) on the importance of screenings, diagnoses, and patient monitoring.

02/11/2026

In their review of emerging research and technologies, Diabettech gets to the key point: "As of February 5, 2026, the signal cutting through the noise has shifted from hardware on the skin to the deep cellular architecture of the body. From 'immune niches' that act as early-warning systems to cell therapies that refuse to quit after seven years, the frontier of diabetes care is officially moving inside."

The Daily Bolus: Early Warnings, Genetic Cloaks, and the Seven-Year Shield | Diabettech - Diabetes and Technology https://www.diabettech.com/the-daily-bolus-early-warnings-genetic-cloaks-and-the-seven-year-shield/

Whilst the title of this edition sounds like something out of science fiction, in it we see a masterclass in "biological intelligence." As of February 5, 2026, the signal cutting through the noise has shifted from hardware on the skin to the deep cellular architecture of the body. From "immune niche...

02/10/2026

Learn the 3 stages of how type 1 diabetes progresses from detection to treatment phases.

We encourage everyone to get screened for before symptoms appear, especially since too often those symptoms may be ignored, putting a person at significant health risk. FREE screenings are available. Visit our screening program website at ASKhealth.org

Visit STOPT1Dprogram.org to access important resources - including a free course covering T1D screening, diagnoses, and monitoring created especially for health care providers by the Barbara Davis Center for Diabetes (BarbaraDavisCenter.org).